1,115
Views
8
CrossRef citations to date
0
Altmetric
Diabetes

Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia

, , , , , & show all
Pages 1605-1611 | Received 09 Jan 2018, Accepted 09 May 2018, Published online: 12 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Viswanathan Mohan, Abdul Zargar, Manoj Chawla, Ameya Joshi, Usha Ayyagari, Bipin Sethi, Kumar Gaurav, Usha Rani H Patted, Seema Vikas Bhagat & Amey Ishwara Mane. (2021) Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study. Diabetes, Metabolic Syndrome and Obesity 14, pages 2925-2933.
Read now

Articles from other publishers (7)

Sanjay Kalra, Abdul Hamid Zargar, GR Sridhar, Ashok Kumar Das, Jamal Ahmed, Jagdish Chander Mohan, G Vijayakumar, Ajay Kumar, Rakesh Kumar Sahay, Vageesh Ayer, Kaushik Pandit, Ganapathi Bantwal, Arun Srinivas, AG Unnikrishnan, Sushil Jindal, Saumitra Ray, Manash P Baruah, Kajal Ganguly, Sachin Mittal, Ameya Joshi, Joe George, Ganesh HK, Nitin Kapoor, Santosh Ramakrishnan, Chetan Shah, Atul Dhingra & Balram Sharma. (2024) Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective. Clinical Medicine Insights: Endocrinology and Diabetes 17.
Crossref
P Panneerselvam, Dibakar Biswas, Hema Singh, K Dilip Kumar, P Ravi Kumar, Pramila Kalra, Santosh Revankar & Sona Warrier. (2023) Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus. Cureus.
Crossref
GR Sridhar, Kaushik Pandit, Sona Warrier & Ashish Birla. (2023) Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review. Cureus.
Crossref
Manoj Chawla, Purvi Chawla, Pratap Jethwani, Kiran Shah & Sanjay Reddy. (2023) Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports. Clinics and Practice 13:2, pages 497-504.
Crossref
Konkanok Wattana, Natnicha Poonchuay & Suriyon Uitrakul. (2022) Efficacy of vildagliptin on 10-year cardiovascular risk reduction in Thai patients with type 2 diabetes mellitus: A real-world observational study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:3, pages 102437.
Crossref
Surendra Kumar. (2021) Comparison of safety and efficacy of glimepiride-metformin and vildagliptin- metformin treatment in newly diagnosed type 2 diabetic patients. Indian Journal of Endocrinology and Metabolism 25:4, pages 326.
Crossref
. (2018) Metformin/vildagliptin. Reactions Weekly 1719:1, pages 141-141.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.